Choose from three concentration presetseasy dosing at 2.5 mg/mL, standard at 5 mg/mL, or concentrated at 10 mg/mLor specify your own target
Research indicates that GLP-1 receptor agonists (GLP-1 RAs) can lead to a significant reduction in visceral adipose tissue (VAT).5 This is a crucial finding because visceral fat is a primary contributor to many metabolic diseases
Potential Implications: The peptides efficacy in healing gastrointestinal fistulas and anastomoses suggests potential therapeutic applications in related conditions
Official website: What is the return policy and is the 60-day guarantee real
& de Araujo, I
(5) A Nakamura, M Nakashima, T Sugao, H Kanemoto, et al (1988) Potent antinociceptive effect of centrally administered delta-sleep-inducing peptide (DSIP) European Journal Pharmacology, 1988 Oct 18, Volume 155 (Issue 3), Pages 247-53